Your browser doesn't support javascript.
Prospective validation of a proteomic urine test for early and accurate prognosis of critical course complications in patients with SARS-CoV-2 infection
German Clinical Trials Register; 25/08/2020; TrialID: DRKS00022495
Clinical Trial Register | ICTRP | ID: ictrp-DRKS00022495
ABSTRACT

Condition

;U07.1 - Emergency use of U07.1

Intervention

Intervention 1 Not applicable (observational study)
Patients are screened for their urinary proteome and compared whether a proteome risk score is associated with the clinical severity of Covid-19 disease

Primary 

outcome:

Predictive strength of a urine protein fragment pattern (proteomics) for the severity of Covid19 disease

Criteria

Inclusion criteria Covid-19 disease
Ability for informed consent

Exclusion criteria Anuria
Collection: Clinical trial registers Database: ICTRP Year: 2020 Document Type: Clinical Trial Register

Similar

MEDLINE

...
LILACS

LIS

Collection: Clinical trial registers Database: ICTRP Year: 2020 Document Type: Clinical Trial Register